|
|
Volumn 13, Issue 1, 2006, Pages 49-57
|
|
A pilot phase II study of capecitabine in advanced or recurrent breast cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
CAPECITABINE;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
PRODRUG;
ADULT;
AGED;
ARTICLE;
BONE TUMOR;
BREAST TUMOR;
CANCER STAGING;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
FEMALE;
HUMAN;
LIVER TUMOR;
LUNG TUMOR;
LYMPH NODE METASTASIS;
METASTASIS;
MIDDLE AGED;
ORAL DRUG ADMINISTRATION;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
PILOT STUDY;
SAMPLE SIZE;
SURVIVAL RATE;
TREATMENT OUTCOME;
TUMOR RECURRENCE;
ADMINISTRATION, ORAL;
ADULT;
AGED;
ANTIMETABOLITES, ANTINEOPLASTIC;
BONE NEOPLASMS;
BREAST NEOPLASMS;
DEOXYCYTIDINE;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
LIVER NEOPLASMS;
LUNG NEOPLASMS;
LYMPHATIC METASTASIS;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
PILOT PROJECTS;
PRODRUGS;
SAMPLE SIZE;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
|
EID: 33646694562
PISSN: 13406868
EISSN: None
Source Type: Journal
DOI: 10.2325/jbcs.13.49 Document Type: Article |
|
Times cited : (18)
|
|
References (0)
|
